Journal Article

Efficacy of cotrimoxazole (Sulfamethoxazole-Trimethoprim) as a salvage therapy for the treatment of bone and joint infections (BJIs)

Bouchand, Frédérique, Dinh, Aurélien, Tritz, Thomas, Nich, Christophe, Bauer, Thomas, Rottman, Martin, Bessis, Simon, Salomon, Jérome, Deconinck, Laurene, Matt, Morgan, Senard, Olivia, Davido, Benjamin

2019

Overview

Cotrimoxazole (Sulfamethoxazole-Trimethoprim, SXT) has interesting characteristics for the treatment of bone and joint infection (BJI): a broad spectrum of activity with adequate bone diffusion and oral and intravenous formulations. However, its efficacy and safety in BJIs are poorly documented and its use remains limited. We conducted a retrospective study in 2 reference centers for BJIs from 2013 to 2018 among patients treated with SXT for a BJI. Data were collected from patient's medical charts. Outcomes and adverse events were evaluated at day (D)7, D45 and D90. We analyzed 51 patients with a mean age of 60 ± 20 (SD) years of which 76% presented with an orthopedic device infection (ODI). Gram-negative bacilli (GNB) were involved in 47% of BJIs (n = 24). Moreover, they were often polymicrobial infections (41%). Doses of SXT ranged from 800/160mg bid (61%; n = 31) to 800/160mg tid (39%; n = 20). Median SXT treatment duration was 45 days (IQR 40-45). SXT was part of a dual therapy in 84% of patients (n = 43), associated mainly with fluoroquinolones (n = 17) or rifampicin (n = 14). Outcome was favorable at D7 in 98% (n = 50), at D45 in 88.2% (n = 45) and at D90 in 78.4% (n = 40). The second agent combined with SXT was not an independent factor of favorable outcome (p = 0.97). Adverse events were reported in 8% (n = 4) of patients, with a median of 21 days (IQR 20-30) from SXT initiation and led to discontinuation (n = 3). SXT appears to be effective for treatment of BJIs as a salvage therapy, even in GNB or polymicrobial infection, including ODI. Further data are needed to confirm SXT efficacy as an alternative oral regimen in BJIs.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Adult / Aged / Anti-Bacterial Agents - therapeutic use / Antibiotics / Antimicrobial agents / Bacilli / Biology and life sciences / Bone Diseases, Infectious - drug therapy / Bone Diseases, Infectious - microbiology / Cotrimoxazole / Effectiveness / Female / Fluoroquinolones / Gram-negative bacilli / Gram-Negative Bacteria - isolation & purification / Gram-Negative Bacterial Infections - drug therapy / Gram-Negative Bacterial Infections - microbiology / Humans / Infections / Intravenous administration / Joint diseases / Joints (anatomy) / Male / Medicine and Health Sciences / Middle Aged / Orthopedics / Patients / Prostheses / Prosthesis-Related Infections - drug therapy / Prosthesis-Related Infections - microbiology / Research and Analysis Methods / Retrospective Studies / Rifampin / Salvage Therapy / Staphylococcus infections / Sulfamethoxazole / Therapy / Trimethoprim / Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use